Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 249

1.

HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.

Ahmed N, Salsman VS, Kew Y, Shaffer D, Powell S, Zhang YJ, Grossman RG, Heslop HE, Gottschalk S.

Clin Cancer Res. 2010 Jan 15;16(2):474-85. doi: 10.1158/1078-0432.CCR-09-1322. Epub 2010 Jan 12.

PMID:
20068073
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.

Hegde M, Corder A, Chow KK, Mukherjee M, Ashoori A, Kew Y, Zhang YJ, Baskin DS, Merchant FA, Brawley VS, Byrd TT, Krebs S, Wu MF, Liu H, Heslop HE, Gottachalk S, Yvon E, Ahmed N.

Mol Ther. 2013 Nov;21(11):2087-101. doi: 10.1038/mt.2013.185. Epub 2013 Aug 13.

PMID:
23939024
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Regression of experimental medulloblastoma following transfer of HER2-specific T cells.

Ahmed N, Ratnayake M, Savoldo B, Perlaky L, Dotti G, Wels WS, Bhattacharjee MB, Gilbertson RJ, Shine HD, Weiss HL, Rooney CM, Heslop HE, Gottschalk S.

Cancer Res. 2007 Jun 15;67(12):5957-64.

PMID:
17575166
[PubMed - indexed for MEDLINE]
Free Article
4.

Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.

Kahlon KS, Brown C, Cooper LJ, Raubitschek A, Forman SJ, Jensen MC.

Cancer Res. 2004 Dec 15;64(24):9160-6.

PMID:
15604287
[PubMed - indexed for MEDLINE]
Free Article
5.

PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor.

Nakazawa Y, Huye LE, Salsman VS, Leen AM, Ahmed N, Rollins L, Dotti G, Gottschalk SM, Wilson MH, Rooney CM.

Mol Ther. 2011 Dec;19(12):2133-43. doi: 10.1038/mt.2011.131. Epub 2011 Jul 19.

PMID:
21772253
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.

Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, Konda B, Black KL, Yu JS.

Stem Cells. 2009 Aug;27(8):1734-40. doi: 10.1002/stem.102.

PMID:
19536809
[PubMed - indexed for MEDLINE]
Free Article
7.

Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.

Haynes NM, Trapani JA, Teng MW, Jackson JT, Cerruti L, Jane SM, Kershaw MH, Smyth MJ, Darcy PK.

Blood. 2002 Nov 1;100(9):3155-63. Erratum in: Blood. 2003 May 15;101(10):3808.

PMID:
12384413
[PubMed - indexed for MEDLINE]
Free Article
8.

Identification of novel human leukocyte antigen-A*0201-restricted, cytotoxic T lymphocyte epitopes on CD133 for cancer stem cell immunotherapy.

Ji J, Judkowski VA, Liu G, Wang H, Bunying A, Li Z, Xu M, Bender J, Pinilla C, Yu JS.

Stem Cells Transl Med. 2014 Mar;3(3):356-64. doi: 10.5966/sctm.2013-0135. Epub 2013 Dec 27.

PMID:
24375541
[PubMed - indexed for MEDLINE]
9.

NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.

Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG.

Stem Cells. 2010 Jan;28(1):5-16. doi: 10.1002/stem.254.

PMID:
19904829
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells.

Kong S, Sengupta S, Tyler B, Bais AJ, Ma Q, Doucette S, Zhou J, Sahin A, Carter BS, Brem H, Junghans RP, Sampath P.

Clin Cancer Res. 2012 Nov 1;18(21):5949-60. doi: 10.1158/1078-0432.CCR-12-0319. Epub 2012 Sep 10.

PMID:
22966020
[PubMed - indexed for MEDLINE]
Free Article
11.

Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma.

Shen CJ, Yang YX, Han EQ, Cao N, Wang YF, Wang Y, Zhao YY, Zhao LM, Cui J, Gupta P, Wong AJ, Han SY.

J Hematol Oncol. 2013 May 9;6:33. doi: 10.1186/1756-8722-6-33.

PMID:
23656794
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects.

van de Water JA, Bagci-Onder T, Agarwal AS, Wakimoto H, Roovers RC, Zhu Y, Kasmieh R, Bhere D, Van Bergen en Henegouwen PM, Shah K.

Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16642-7. doi: 10.1073/pnas.1202832109. Epub 2012 Sep 25.

PMID:
23012408
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

T cells redirected to EphA2 for the immunotherapy of glioblastoma.

Chow KK, Naik S, Kakarla S, Brawley VS, Shaffer DR, Yi Z, Rainusso N, Wu MF, Liu H, Kew Y, Grossman RG, Powell S, Lee D, Ahmed N, Gottschalk S.

Mol Ther. 2013 Mar;21(3):629-37. doi: 10.1038/mt.2012.210. Epub 2012 Oct 16.

PMID:
23070117
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Stem-like tumor-initiating cells isolated from IL13R╬▒2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells.

Brown CE, Starr R, Aguilar B, Shami AF, Martinez C, D'Apuzzo M, Barish ME, Forman SJ, Jensen MC.

Clin Cancer Res. 2012 Apr 15;18(8):2199-209. doi: 10.1158/1078-0432.CCR-11-1669. Epub 2012 Mar 8.

PMID:
22407828
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.

Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, Jeon JW, Kim MH, Kang BG, Jung Y, Jin J, Hong SC, Park WY, Lee DS, Kim H, Nam DH.

Lab Invest. 2008 Aug;88(8):808-15. doi: 10.1038/labinvest.2008.57. Epub 2008 Jun 16.

PMID:
18560366
[PubMed - indexed for MEDLINE]
Free Article
16.

Immunotherapy targeting glioma stem cells--insights and perspectives.

Li Z, Lee JW, Mukherjee D, Ji J, Jeswani SP, Black KL, Yu JS.

Expert Opin Biol Ther. 2012 Feb;12(2):165-78. doi: 10.1517/14712598.2012.648180. Epub 2011 Dec 26. Review.

PMID:
22200324
[PubMed - indexed for MEDLINE]
17.

On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.

Stechishin OD, Luchman HA, Ruan Y, Blough MD, Nguyen SA, Kelly JJ, Cairncross JG, Weiss S.

Neuro Oncol. 2013 Feb;15(2):198-207. doi: 10.1093/neuonc/nos302. Epub 2012 Dec 21.

PMID:
23262510
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.

Wakimoto H, Kesari S, Farrell CJ, Curry WT Jr, Zaupa C, Aghi M, Kuroda T, Stemmer-Rachamimov A, Shah K, Liu TC, Jeyaretna DS, Debasitis J, Pruszak J, Martuza RL, Rabkin SD.

Cancer Res. 2009 Apr 15;69(8):3472-81. doi: 10.1158/0008-5472.CAN-08-3886. Epub 2009 Apr 7.

PMID:
19351838
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Generation of tumor-reactive CTL against the tumor-associated antigen HER2 using retrovirally transduced dendritic cells derived from CD34+ hemopoietic progenitor cells.

Meyer zum B├╝schenfelde C, Nicklisch N, Rose-John S, Peschel C, Bernhard H.

J Immunol. 2000 Oct 1;165(7):4133-40.

PMID:
11034426
[PubMed - indexed for MEDLINE]
Free Article
20.

HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.

Liu G, Ying H, Zeng G, Wheeler CJ, Black KL, Yu JS.

Cancer Res. 2004 Jul 15;64(14):4980-6.

PMID:
15256472
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk